BioStem Technologies to Host Third Quarter Financial Results and Corporate Update Conference Call
November 15, 2022 07:30 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Nov. 15, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Technologies® CEO to Appear on the Benzinga All Access Show on June 17,2022
June 17, 2022 09:25 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA, June 17, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies® (OTC: BSEM), a leading, innovator focused on harnessing the natural properties of perinatal tissue in the development,...
BioStem Technologies Reports Record Breaking Second Quarter Sales
August 25, 2021 11:15 ET
|
BioStem Technologies, Inc.
Company on Pace to Exceed 2020 Revenues in 2021 Pompano Beach, Fl., Aug. 25, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life...
BioStem Technologies, in Partnership with Veterans Medical Distributors Inc., Announces Five-Year Federal Supply Schedule Contract with the Department of Veterans Affairs
September 01, 2020 17:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., Sept. 01, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue...
BioStem Technologies, Inc. Announces Update Regarding Timeline to Become Current Reporting with OTC Markets During Q4 2020
July 22, 2020 17:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, July 22, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) a leading life sciences company specializing in the development and sale of perinatal tissue-based...